325 results on '"Zipeto, Donato"'
Search Results
2. SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals
3. Advanced Cellular Models for Rare Disease Study: Exploring Neural, Muscle and Skeletal Organoids
4. Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
5. Gα15 in early onset of pancreatic ductal adenocarcinoma
6. Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve
7. Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma
8. Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression.
9. Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization
10. Expression of FBXW11 in normal and disease‐associated osteogenic cells
11. Publisher Correction: Runx2 stimulates neoangiogenesis through the Runt domain in melanoma
12. Benzodiazepine Use and HIV-Associated Neurocognitive Impairment: Which Comes First?
13. Editorial: Nanomaterials for the diagnosis and therapy of viral infections
14. Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection
15. Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
16. Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients
17. Testing the performance of the imputation of MHC region in large datasets when using different reference panels
18. Additional file 2 of Different decay of antibody response and VOC sensitivity in na��ve and previously infected subjects at 15 weeks following vaccination with BNT162b2
19. Additional file 3 of Different decay of antibody response and VOC sensitivity in na��ve and previously infected subjects at 15 weeks following vaccination with BNT162b2
20. Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
21. COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder
22. Cytomegalovirus gB Genotype Distribution Differs in Human Immunodeficiency Virus-Infected Patients and Immunocompromised Allograft Recipients
23. Antibody response to BTN162b2 mRNA vaccination in naïve versus SARS-CoV-2 infected subjects with and without waning immunity
24. Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies
25. Coinfection with HIV-1 and human T-cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS
26. SARS-CoV-2 Vaccination Elicits Unconventional IgM Specific Responses in Naïve and Previously COVID19-Infected Individuals
27. HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex
28. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
29. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
30. A fast and reliable method for detecting SNP rs67384697 (Hsa‐miR‐148a binding site) by a single run of allele‐specific real‐time PCR
31. The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases
32. A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells
33. Molecular and Lifestyle Factors Modulating Obesity Disease
34. NF-κB and MicroRNA Deregulation Mediated by HTLV-1 Tax and HBZ
35. CRISPR/Cas system: An emerging technology in stem cell research
36. Involvement of HLA-C binding stability to β2-microglobulin in HIV-1 infection
37. HLA-C and HIV-1: friends or foes?
38. The Runt domain of RUNX2 induces the migration of melanoma cells to bone
39. TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins
40. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma
41. Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
42. Inflammation in Cancer: Part of the Problem or Part of the Solution?
43. New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration
44. Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells
45. Analysis of colorectal cancers for human cytomegalovirus presence
46. HLA-C increases HIV-1 infectivity and is associated with gp120
47. HTLV-1 BASIC LEUCIN ZIPPER FACTOR AND ITS HOMOLOGOUS APH-2 IMPAIR NF-κB ACTIVATION MEDIATED BY THE VIRAL ONCOPROTEIN TAX
48. CRISPR/Cas9 as a tool for the study of the interactions between viruses and host
49. A CRISPR/Cas9 based approach to study the implication of HTLV regulatory proteins in the NF-κB modulation
50. HTLV ANTISENSE PROTEINS ROLE IN THE NF-κB MODULATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.